Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Low Protein Expression of both ATRX and ZNRF3 as Novel Negative Prognostic Markers of Adult Adrenocortical Carcinoma

Full text
Author(s):
Show less -
Brondani, Vania Balderrama [1] ; Lacombe, Amanda Meneses Ferreira [1] ; Mariani, Beatriz Marinho de Paula [2] ; Montenegro, Luciana [2, 3] ; Soares, Ibere Cauduro [4, 5] ; Bezerra-Neto, Joao Evangelista [6] ; Tanno, Fabio Yoshiaki [7] ; Srougi, Victor [7] ; Chambo, Jose Luis [7] ; Mendonca, Berenice Bilharinho [1, 2, 3] ; Almeida, Madson Q. [1, 2, 8] ; Zerbini, Maria Claudia Nogueira [4] ; Fragoso, Maria Candida Barisson Villares [1, 2, 8]
Total Authors: 13
Affiliation:
[1] Univ Sao Paulo, Fac Med, Unidade Suprarrenal, Serv Endocrinol & Metabol, Hosp Clin, Av Dr Eneas Carvalho Aguiar 155, BR-05403900 Sao Paulo - Brazil
[2] Univ Sao Paulo, Fac Med, Hosp Clin, Lab Hormonios & Genet Mol LIM 42, Av Dr Eneas Carvalho Aguiar 255, BR-05403900 Sao Paulo - Brazil
[3] Univ Sao Paulo, Fac Med, Lab Sequenciamento Larga Escala SELA, Av Dr Arnaldo 455, BR-01246903 Sao Paulo - Brazil
[4] Univ Sao Paulo, Fac Med, Dept Patol, Av Dr Arnaldo 455, BR-01246903 Sao Paulo - Brazil
[5] Univ Sao Paulo, Fac Med, Serv Anat Patol, Inst Canc Estado Sao Paulo ICESP, Av Dr Arnaldo 251, BR-01246000 Sao Paulo - Brazil
[6] Univ Sao Paulo, Fac Med, Serv Oncol, Inst Canc Estado Sao Paulo ICESP, Av Dr Arnaldo 251, BR-01246000 Sao Paulo - Brazil
[7] Univ Sao Paulo, Fac Med, Serv Urol, Hosp Clin, Av Dr Eneas Carvalho Aguiar 155, BR-05403900 Sao Paulo - Brazil
[8] Univ Sao Paulo, Fac Med, Serv Endocrinol, Inst Canc Estado Sao Paulo ICESP, Av Dr Arnaldo 251, BR-01246000 Sao Paulo - Brazil
Total Affiliations: 8
Document type: Journal article
Source: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES; v. 22, n. 3 FEB 2021.
Web of Science Citations: 0
Abstract

Adrenocortical carcinoma (ACC) is a rare malignancy that is associated with a dismal prognosis. Pan-genomic studies have demonstrated the involvement of ATRX and ZNRF3 genes in adrenocortical tumorigenesis. Our aims were to evaluate the protein expression of ATRX and ZNRF3 in a cohort of 82 adults with ACC and to establish their prognostic value. Two pathologists analyzed immuno-stained slides of a tissue microarray. The low protein expression of ATRX and ZNRF3 was associated with a decrease in overall survival (OS) (p = 0.045, p = 0.012, respectively). The Cox regression for ATRX protein expression of >1.5 showed a hazard ratio (HR) for OS of 0.521 (95% CI 0.273-0.997; p = 0.049) when compared with <= 1.5; for ZNRF3 expression >2, the HR for OS was 0.441 (95% CI, 0.229-0.852; p = 0.015) when compared with <= 2. High ATRX and ZNRF3 protein expressions were associated with optimistic recurrence-free survival (RFS) (p = 0.027 and p = 0.005, respectively). The Cox regression of RFS showed an HR of 0.332 (95%CI, 0.111-0.932) for ATRX expression >2.7 (p = 0.037), and an HR of 0.333 (95%CI, 0.140-0.790) for ZNRF3 expression >2 (p = 0.013). In conclusion, low protein expression of ATRX and ZNRF3 are negative prognostic markers of ACC; however, different cohorts should be evaluated to validate these findings. (AU)

FAPESP's process: 17/26345-5 - Evaluation of prognostic factors of adrenal cortex tumors and predictors of response to treatment with mitotane in carcinomas
Grantee:Maria Candida Barisson Villares Fragoso
Support Opportunities: Regular Research Grants